In case of double expressor DLBCL, seventeen cases were evaluated, with six cases (35.3%) having a Ki-67 labeling index greater than 80% and 11 cases (64.7%) having a Ki-67 labeling index less than 80% (Figure 3). This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.